Přístupnostní navigace
E-application
Search Search Close
Publication detail
DOSTÁLOVÁ, S. ČERNÁ, T. HYNEK, D. KOUDELKOVÁ, Z. VACULOVIČ, T. KOPEL, P. HRABĚTA, J. HEGER, Z. VACULOVIČOVÁ, M. ECKSCHLAGER, T. ADAM, V.
Original Title
Site-Directed Conjugation of Antibodies to Apoferritin Nanocarrier for Targeted Drug Delivery to Prostate Cancer Cells
Type
journal article in Web of Science
Language
English
Original Abstract
Herein, we describe a novel approach for targeting of ubiquitous protein apoferritin (APO)-encapsulating doxorubicin (DOX) to prostate cancer using antibodies against prostatespecific membrane antigen (PSMA). The conjugation of anti-PSMA antibodies and APO was carried out using HWRGWVC heptapeptide, providing their site-directed orientation. The prostatecancer- targeted and nontargeted nanocarriers were tested using LNCaP and HUVEC cell lines. A total of 90% of LNCaP cells died after treatment with DOX (0.25 μM) or DOX in nontargeted and prostate-cancer-targeted APO, proving that the encapsulated DOX toxicity for LNCaP cells remained the same. Free DOX showed higher toxicity for nonmalignant cells, whereas the toxicity was lower after treatment with the same dosage of APO-encapsulated DOX (APODOX) and even more in prostate-cancer-targeted APODOX. Hemolytic assay revealed exceptional hemocompatibility of the entire nanocarrier. The APO encapsulation mechanism ensures applicability using a wide variety of chemotherapeutic drugs, and the presented surface modification enables targeting to various tumors.
Keywords
antibodies, apoferritin, doxorubicin, nanomedicine, targeted drug delivery
Authors
DOSTÁLOVÁ, S.; ČERNÁ, T.; HYNEK, D.; KOUDELKOVÁ, Z.; VACULOVIČ, T.; KOPEL, P.; HRABĚTA, J.; HEGER, Z.; VACULOVIČOVÁ, M.; ECKSCHLAGER, T.; ADAM, V.
Released
15. 6. 2016
ISBN
1944-8252
Periodical
ACS applied materials & interfaces
Year of study
8
Number
23
State
United States of America
Pages from
14430
Pages to
14441
Pages count
12
BibTex
@article{BUT126821, author="Simona {Dostálová} and Tereza {Černá} and David {Hynek} and Zuzana {Koudelková} and Tomáš {Vaculovič} and Pavel {Kopel} and Jan {Hraběta} and Zbyněk {Heger} and Markéta {Vaculovičová} and Tomáš {Eckschlager} and Vojtěch {Adam}", title="Site-Directed Conjugation of Antibodies to Apoferritin Nanocarrier for Targeted Drug Delivery to Prostate Cancer Cells", journal="ACS applied materials & interfaces", year="2016", volume="8", number="23", pages="14430--14441", doi="10.1021/acsami.6b04286", issn="1944-8252" }